(Q43987747)

28 November 2017

title

Kidney failure after treatment with 90Y-DOTATOC. (English)

1 reference

28 November 2017

1 reference

Tilmann Schumacher

1

1 reference

28 November 2017

Christian Waldherr

series ordinal

2

1 reference

28 November 2017

Jan Mueller-Brand

series ordinal

3

1 reference

28 November 2017

Helmut Maecke

series ordinal

4

1 reference

28 November 2017

publication date

1 March 2002

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

28 November 2017

published in

1 reference

28 November 2017

volume

29

1 reference

28 November 2017

issue

3

1 reference

28 November 2017

page(s)

435

1 reference

https://scigraph.springernature.com/pub.10.1007/s00259-001-0720-2

28 November 2017

exact match

0 references

cites work

End-stage renal disease after treatment with 90Y-DOTATOC.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-001-0720-2

Between the Scylla and Charybdis of peptide radionuclide therapy: hitting the tumor and saving the kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-001-0720-2

Cerebral deafferentiation in operated gliomas as a predictor for malignancy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-001-0720-2

Amino acid infusion blocks renal tubular uptake of an indium-labelled somatostatin analogue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-001-0720-2

Reducing the renal uptake of radiolabeled antibody fragments and peptides for diagnosis and therapy: present status, future prospects and limitations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-001-0720-2

A new cause of renal thrombotic microangiopathy: yttrium 90-DOTATOC internal radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-001-0720-2

Reduction of the renal uptake of radiolabeled monoclonal antibody fragments by cationic amino acids and their derivatives

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/12002721

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Yttrium-90 DOTATOC: first clinical results

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/12002721

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

D-lysine reduction of indium-111 octreotide and yttrium-90 octreotide renal uptake

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/12002721

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S00259-001-0720-2

1 reference

28 November 2017

1 reference